RETN and colorectal carcinoma: This study demonstrated that resistin treatment could induce NLRP3 expression in human CRC HCT-116 and DLD-1 cells; on the contrary, the inhibition of NLRP3 expression could reduce the 5-FU-induced cytotoxic effect on CRC cells.